Health officials have given a life-extending drug the green light for widespread NHS, giving hope to thousands of men facing a "death sentence" from prostate cancer.
The National Institute for Health and Care Excellence (Nice) said the drug enzalutamide, also known as xtandi, should be considered for use in the treatment of men with hormone relapsed prostate cancer that has spread to other parts of the body.
Nice said in its draft guidance that it was pleased to recommend the drug, which is manufactured by Astellas Pharma, for patients who have few other treatment options left.
More top news
Star Wars actress Carrie Fisher has hit out at the "messed up" film industry where "the only thing that matters is weight and appearance".
US marine Joseph Scott Pemberton has been found guilty of killing a transgender woman in a Philippines hotel.
A young mother has accused an Uber driver of attacking her after a row over making two drop-offs.